NANO-RHEOLOGICAL BIOMARKERS FOR IMPROVED MONITORING OF PATHOLOGIES ASSOCIATED WITH ALTERED RED BLOOD CELL DEFORMABILITY

Drépanocytose

Erythrocyte disorders such as sickle cell disease and hereditary spherocytosis represent a growing public health challenge due to the increasing diversity of the French population. Ektacytometry, the reference technique for measuring erythrocyte deformability, has intrinsic technical limitations: it measures the average deformability of red blood cell populations without capturing cellular heterogeneity, and its cost remains high. To overcome these challenges, the inventors have developed a method based on molecular rotors whose fluorescence emission is correlated to red blood cell rigidity. This technology can quantify both single-cell rheology and the mechanical heterogeneity within cell populations, a key parameter in determining the severity of erythrocyte disorders. This innovative approach aims to improve the diagnosis of membrane disorders pathologies and the prognosis of both sickle cell-anemia and spherocytosis.

Applications

  • Spherocytosis diagnostic
  • Drepanocytosis diagnostic
  • Erythrocyte disorders

Competitive advantages

  • Quantification of the mechanical heterogeneity in cell population
  • Costs
  • Easy-to-use

Intellectual property

WO2020/249823

Keywords

Drepanocytosis - Spherocytosis - Red blood cell - Ektacytometry - Molecular rotor

Download the technology sheet

Everything is accelerating.
What about you?

Erganeo is at your disposal.

your topic
For any information concerning personal data, consult the legal notices.